Hong Yang
70Patents
12h-index
158Co-inventors
87Inventor score
Filing activity: Sep 29, 1995 → Dec 22, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9493476B2 | Macrocyclic compounds as trk kinase inhibitors | Emerging Cross-Sectional Technologies | 43 | Active |
| US8367670B2 | Modulators of toll-like receptors | Emerging Cross-Sectional Technologies | 29 | Active |
| US9127006B2 | Modulators of toll-like receptors | Emerging Cross-Sectional Technologies | 24 | Active |
| US7732616B2 | Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof | Chemistry; Metallurgy | 22 | Active |
| US9718822B2 | Macrocyclic compounds as Trk kinase inhibitors | Emerging Cross-Sectional Technologies | 22 | Active |
| US9902741B2 | Macrocyclic compounds as TRK kinase inhibitors | Emerging Cross-Sectional Technologies | 22 | Active |
| US9840519B2 | Macrocyclic compounds as TRK kinase inhibitors | Emerging Cross-Sectional Technologies | 21 | Active |
| US9750744B2 | Macrocyclic compounds as Trk kinase inhibitors | Emerging Cross-Sectional Technologies | 21 | Active |
| US7166585B2 | 24-Sulfur-substituted analogs of 1α,25-dihydroxy vitamin D3 | Chemistry; Metallurgy | 19 | Expired |
| US7230099B2 | Heterocyclic inhibitors of MEK and methods of use thereof | Chemistry; Metallurgy | 17 | Expired |
| US8629142B2 | Modulators of toll-like receptors | Emerging Cross-Sectional Technologies | 14 | Active |
| US11084832B2 | Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use | Chemistry; Metallurgy | 12 | Active |
| US8809527B2 | Modulators of toll-like receptors | Emerging Cross-Sectional Technologies | 11 | Active |
| US7517994B2 | Heterocyclic inhibitors of MEK and methods of use thereof | Chemistry; Metallurgy | 10 | Active |
| US7598383B2 | Heterocyclic inhibitors of MEK and methods of use thereof | Chemistry; Metallurgy | 10 | Active |
| US9452166B2 | Modulators of toll-like receptors | Emerging Cross-Sectional Technologies | 10 | Active |
| US10703733B2 | MCL-1 inhibitors | Human Necessities | 10 | Active |
| US10988451B2 | MCL-1 inhibitors | Human Necessities | 9 | Active |
| US8338593B2 | Modulators of toll-like receptor 7 | Human Necessities | 9 | Active |
| US10172860B2 | Modulators of toll-like receptors | Emerging Cross-Sectional Technologies | 8 | Active |
| US8691809B2 | Substituted benzoazepines as toll-like receptor modulators | Chemistry; Metallurgy | 8 | Active |
| US11613546B2 | Substituted pyridotriazine compounds and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US7893065B2 | Heterocyclic inhibitors of MEK and methods of use thereof | Chemistry; Metallurgy | 7 | Active |
| US7538120B2 | Method of treating inflammatory diseases | Chemistry; Metallurgy | 7 | Active |
| US11548902B1 | Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use | Chemistry; Metallurgy | 7 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.